Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 1865 new people
  • 34 new organizations
  • 622 new photos
  • 1247 job history records for people in our database
  • 518 education records for people in our database
  • 2209 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 198 new policy reports
  • 12 new trips to our privately funded travel database
  • 921 new personal financial disclosures
  • 27459 new press releases
  • 30 new town halls

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

Health: FDA Review Times

  Premium   Download PDF Now (17 pages)
Report Type Reports and Testimonies
Report Date May 2, 1996
Report No. T-PEMD-96-9
Subject
Summary:

New drug applications are moving more quickly through the Food and Drug Administration's (FDA) review and approval process. It now takes about the same amount of time to receive approval in the United States as it does in the United Kingdom. FDA review times for medical device applications vary widely from one year to the next. For all types of applications, the median review time rose dramatically in the early 1990s and then began to fall. Whether this downturn will continue will become clear as data for additional years become available. Some aspects of the new drug and medical device review systems introduced by the European Union (EU) in 1995 differ significantly from FDA's approach to medical product review, and there is great optimism in the EU about their prospects. However, it is still to early to tell whether the EU approach will result in more efficient reviews while ensuring product safety.

« Return to search Government Accountability Office reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com